MedPath
FDA Approval

Linezolid

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
November 17, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Linezolid(600 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Amneal Pharmaceuticals Private Limited

Amneal Pharmaceuticals LLC

915076126

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Linezolid

Product Details

NDC Product Code
65162-777
Application Number
ANDA204536
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
November 17, 2023
LinezolidActive
Code: ISQ9I6J12JClass: ACTIBQuantity: 600 mg in 1 1
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
ETHYLCELLULOSESInactive
Code: 7Z8S9VYZ4BClass: IACT
DIETHYL PHTHALATEInactive
Code: UF064M00AFClass: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WOClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
POVIDONEInactive
Code: FZ989GH94EClass: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
TALCInactive
Code: 7SEV7J4R1UClass: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT
© Copyright 2025. All Rights Reserved by MedPath
Linezolid - FDA Approval | MedPath